Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells
Some of the clinical manifestations of MIS-C mimic Kawasaki disease (KD) shock syndrome
14 According to our patent searches, Novo Nordisk has filed 91 patents for formulations, 41 patents covering devices to deliver the drug, and 45 patents for methods of treatment (Figure 6)
Further research is required to broaden the evidence base for DKD therapy by including historically under-represented populations, such as individuals with type 1 diabetes mellitus, advanced chronic kidney disease or kidney transplants
Never forget to celebrate the small wins
This was further substantiated by systematic reviews, which have described pooled overall MACE risk reductions in both the abovementioned population groups